These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3501842)

  • 1. Evidence for two conformational states of 5-hydroxytryptamine carrier in rat cortical synaptosomes.
    Lee JD; Shih JC
    Neuropharmacology; 1987 Dec; 26(12):1667-71. PubMed ID: 3501842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoinactivation of serotonin uptake by an arylazido derivative of 5-hydroxytryptamine.
    Ransom RW; Lee JD; Bolger MB; Shih JC
    Mol Pharmacol; 1985 Aug; 28(2):185-90. PubMed ID: 4022001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes.
    Bonanno G; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):219-25. PubMed ID: 3473290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.
    Stauderman KA; Gandhi VC; Jones DJ
    Life Sci; 1992; 50(26):2125-38. PubMed ID: 1608295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na(+)-dependent, fluoxetine-sensitive serotonin uptake by astrocytes tissue-printed from rat cerebral cortex.
    Dave V; Kimelberg HK
    J Neurosci; 1994 Aug; 14(8):4972-86. PubMed ID: 8046464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
    Ellison DW; Campbell IC
    J Neurochem; 1986 Jan; 46(1):218-23. PubMed ID: 2415679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and chronic tramadol on [3H]-5-HT uptake in rat cortical synaptosomes.
    Giusti P; Buriani A; Cima L; Lipartiti M
    Br J Pharmacol; 1997 Sep; 122(2):302-6. PubMed ID: 9313939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of the relationship between the uptake site for 5-hydroxytryptamine and the high affinity binding site for [3H]imipramine. II. The role of sodium ions.
    Wood MD
    Neuropharmacology; 1987 Aug; 26(8):1081-5. PubMed ID: 2958719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism by which extracellular sodium depletion causes 5-hydroxytryptamine release from rat brain synaptosomes.
    Collard KJ
    Biochim Biophys Acta; 1989 Sep; 984(3):319-25. PubMed ID: 2789079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of fluoxetine and zimelidine on the uptake of 5-hydroxytryptamine and tryptamine by cortical slices and on responses of cortical neurones to stimulation of the nucleus raphe medianus.
    Jones RS; Broadbent J
    Eur J Pharmacol; 1982 Jul; 81(4):681-5. PubMed ID: 6214414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine.
    Berge OG; Chacho D; Hole K
    Eur J Pharmacol; 1983 Jun; 90(2-3):293-6. PubMed ID: 6873188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes.
    Asano S; Matsuda T; Nakasu Y; Maeda S; Nogi H; Baba A
    Jpn J Pharmacol; 1997 Oct; 75(2):123-8. PubMed ID: 9414026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of extracellular sodium removal on the uptake of tryptophan into rat cortical slices and synaptosomes.
    Wilkinson LS; Collard KJ
    J Neurochem; 1984 Jul; 43(1):274-5. PubMed ID: 6726252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor.
    Robertson DW; Jones ND; Swartzendruber JK; Yang KS; Wong DT
    J Med Chem; 1988 Jan; 31(1):185-9. PubMed ID: 3257267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants.
    Hrdina PD
    Eur J Pharmacol; 1987 Jun; 138(2):159-68. PubMed ID: 3040430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
    Fagervall I; Ross SB
    Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.